Monopar to Present at Roth Inaugural Healthcare Opportunities Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WILMETTE, Ill., Sept. 28, 2022 (GLOBE NEWSWIRE) — Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopar’s Chief Executive Officer, will present at the Roth Inaugural Healthcare Opportunities Conference.

Presentation Details:

Date: October 6, 2022
Time: 12:00 p.m. (ET)
Location: The Yale Club, New York City, New York

https://www.roth.com/conferences/upcoming-conferences

About Monopar Therapeutics Inc.

Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Monopar’s pipeline consists of Validive® for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients; camsirubicin for the treatment of advanced soft tissue sarcoma; a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19; and an early-stage camsirubicin analog, MNPR-202, for various cancers. For more information, visit: www.monopartx.com.

CONTACT:  

Monopar Therapeutics Inc.
Investor Relations  
Kim R. Tsuchimoto  
Chief Financial Officer  
kimtsu@monopartx.com

Follow Monopar on social media for updates: 
Twitter: @MonoparTx  LinkedIn: Monopar Therapeutics

 

Staff

Recent Posts

Three Finalists Announced for the 2025 Bloom Burton Award

Recognizing the Year's Most Significant Contributions to Canada's Innovative Healthcare IndustryToronto, Ontario--(Newsfile Corp. - May…

33 minutes ago

Clarivate Enhances OFF-X with Pathway Maps to Accelerate Target Safety Assessments

R&D teams can streamline safety evaluations, reduce risks and enable faster decision-making in drug development…

2 hours ago

Google Cloud and Philips Collaborate to Drive Consumer Marketing Innovation and Transform Digital Asset Management with AI

Google Cloud helps streamline marketing processes, enhancing brand consistency and reducing operational costs AMSTERDAM and…

2 hours ago

Julius Clinical and Peachtree BioResearch Solutions Merge to Form a Fully Integrated Global CRO with Increased CNS Capabilities

ZEIST, Netherlands, May 14, 2025 /PRNewswire/ -- Julius Clinical, a leading full-service Contract Research Organization (CRO)…

2 hours ago

SolarEast Launches Global R290 Heat Pump System to Advance Climate Goals and Energy Efficiency

BEIJING, May 14, 2025 /PRNewswire/ -- SolarEast, a leading manufacturer of air-to-water heat pumps, has…

2 hours ago